דוסטקסל ג'נמדיקס

Kraj: Izrael

Język: hebrajski

Źródło: Ministry of Health

Składnik aktywny:

DOCETAXEL 20 MG/ML

Dostępny od:

GENMEDIX

Kod ATC:

L01CD02

Forma farmaceutyczna:

CONCENTRATE FOR SOLUTION FOR INFUSION

Droga podania:

I.V

Wyprodukowano przez:

SINDAN PHARMA SRL, ROMANIA

Grupa terapeutyczna:

DOCETAXEL

Wskazania:

Breast cancer: docetaxel in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node- positive breast cancer. docetaxel in combination with doxorubicin is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have not previously received cytotoxic therapy for this condition. docetaxel monotherapy is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic therapy. Previous chemotherapy should have included an anthracycline or an alkylating agent. docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumors overexpress HER2 and who previously have not received chemotherapy for metastatic disease. docetaxel in combination with capecitabine is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic chemotherapy. Previous therapy should have included an anthracyclin

Data autoryzacji:

2011-10-01